A recent comprehensive survey among U.S. physicians has illuminated the medical community’s perceptions regarding the feasibility of preserving dying patients for potential future revival—a concept largely popularized by cryonics and advanced preservative techniques. The study, led by Ariel Zeleznikow-Johnston of Monash University and collaborators spanning Australia, Switzerland, and the United States, was published in the open-access journal PLOS One on May 20, 2026. This exploration delves into the ethical, clinical, and practical considerations of preservation technologies, which aspire to overcome current biological limits and enable revival in a future era when advanced medicine might reverse death or related processes.
The notion of preservation hinges on the application of methods that maintain the structural integrity of human tissues at extremely low temperatures or through chemical fixation immediately following death or, potentially, prior to cardiac arrest. In theory, such preservation could arrest the biological degradation processes irreversibly linked to death, thus allowing a future technology to restore life and health. Despite its speculative nature and the absence of demonstrable revival technologies today, this field commands interest as hundreds of individuals worldwide have already elected to undergo such procedures, and many more are registered for future preservation.
The surveyed cohort comprised over three hundred physicians from diverse specialties, including primary care, neurology, intensive care, anesthesia, and palliative medicine. Their responses provide a nuanced snapshot of current medical attitudes toward preservation, revealing a spectrum of beliefs regarding whether revival from preservation might ever be plausible. Approximately one in four physicians expressed a genuine belief in the feasibility of future revival, indicating openness to the foundational assumptions underlying preservation. Neurosurgeons were notably more optimistic, reflecting perhaps their intimate familiarity with brain physiology and injury, while other specialists showed more skepticism and a broader range of opinions.
Technically, the preservation process often involves perfusion fixation or vitrification of the brain and sometimes the entire body, aiming to limit ischemic damage and prevent ice crystal formation that compromises cellular architecture. Apex Neuroscience Brain Bank, featured in the study, utilizes perfusion fixation methods to maintain structural fidelity of the brain post-mortem. The state-of-the-art techniques seek to minimize autolysis and decomposition, two principal barriers to brain preservation, by infusing specialized solutions that stabilize neural circuits and molecular structures critical for identity and memory retention.
The clinical implications for physicians center upon end-of-life care decisions, where patients’ preferences might intersect with experimental preservation options. The survey underscored a general willingness among doctors to prescribe anti-coagulants to dying patients, recognizing that such interventions enhance preservation outcomes by reducing vascular clotting and preserving circulation integrity during the process. However, the endorsement sharply drops when considering pre-mortem procedures such as medically assisted death with intermediary preservation before cardiac arrest. These scenarios pose profound ethical questions, clashing with existing medical standards and legal frameworks, which universally prohibit such practices due to concerns about patient welfare and the definition of death.
Ethically, preservation challenges conventional end-of-life paradigms by introducing uncertainty about death’s finality and medical goals. Physicians expressed concern that increasing the likelihood of successful cryopreservation might conflict with the established priority of providing comfort and dignity in dying. This tension arises because some preservation techniques might require invasive procedures or treatments perceived as burdensome or experimental, challenging the fundamental principles of beneficence and non-maleficence that guide clinical practice. The study highlights the need for clear ethical guidelines that responsibly balance experimental hopes with patient autonomy and clinical integrity.
Legally, the survey notes that pre-cardiac-arrest preservation remains illegal globally, leaving the field in a regulatory gray zone. Future advancements might precipitate legal challenges and necessitate updated legislation to accommodate scenarios where preservation is integrated with end-of-life decisions. The study recommends proactive discourse among healthcare providers, policymakers, and bioethicists to establish frameworks governing these emerging technologies, preventing legal ambiguity and protecting both patients and practitioners.
Physician hesitancy toward preservation often stems from unfamiliarity with the scientific rigor underpinning contemporary techniques. Zeleznikow-Johnston observes that specialists accustomed to end-of-life care and death discussions tend to adopt a more receptive stance, suggesting that exposure and education might mitigate skepticism. This observation implies that familiarity with the biological and technical underpinnings of preservation correlates with greater acceptance, emphasizing the role of targeted outreach and scholarly exchange in bridging gaps between emerging biotechnologies and mainstream clinical practice.
The preservation community currently includes several nonprofit and commercial organizations globally, each pushing the frontier of biostasis research. For instance, Sparks Brain Preservation and Apex Neuroscience—associated with some authors—develop and refine protocols that preserve brain ultrastructure and synaptic integrity, leveraging innovations in cryoprotectants and fixation chemistry. The field also faces ongoing challenges, including optimizing perfusion techniques, minimizing ice formation, preserving molecular markers critical to identity, and verifying preservation quality through ultrastructural analyses using electron microscopy.
This study’s findings reflect a pivotal moment in biostasis research, where speculative science confronts medical pragmatism and societal values. The gradual increase in physician support for preservation-related interventions suggests an evolving openness to integrating futuristic concepts into end-of-life care paradigms, should advancements in revival technologies materialize. Yet, the current landscape requires cautious navigation, balancing hope against evidence and ethics against innovation.
The implications of this research extend beyond cryonics, potentially influencing broader medical dialogues about death, immortality, and the limits of human biology. As preservation technologies mature, they may provoke reconsideration of legal definitions of death, consent processes, and patients’ rights to experimental treatments. Moreover, the philosophical and existential implications arise, questioning how society values life’s continuity and identity when traditional biological death could become reversible.
In conclusion, this physician survey provides a critical empirical baseline for understanding how the medical community currently perceives the feasibility of preserving dying patients for future revival. It underscores the complexity of integrating cutting-edge preservation technologies into clinical practice, highlighting ethical, legal, and scientific challenges that will demand multidisciplinary collaboration. The journey from speculative possibility to clinical reality remains long and uncertain, yet this study marks a significant step in charting the contours of this fascinating frontier in medicine.
Subject of Research: Not applicable
Article Title: Physician estimates of the feasibility of preserving the dying for future revival
News Publication Date: 20-May-2026
Web References:
http://dx.doi.org/10.1371/journal.pone.0348216
https://www.cryodao.org/
References:
Zeleznikow-Johnston A, Kendziorra EF, McKenzie AT (2026) Physician estimates of the feasibility of preserving the dying for future revival. PLoS One 21(5): e0348216.
Image Credits: Apex Neuroscience, CC-BY 4.0
Keywords: Cryonics, brain preservation, end-of-life care, physician attitudes, cryopreservation ethics, medical futurism, perfusion fixation, revival feasibility, neurobiology, legal frameworks, bioethics, biostasis
